Advertisement
HITI vs HKPD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HITI is a Buy and HKPD is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HITI’s FA Score shows that 1 FA rating(s) are green whileHKPD’s FA Score has 0 green FA rating(s).
- HITI’s FA Score: 1 green, 4 red.
- HKPD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HITI’s TA Score shows that 1 TA indicator(s) are bullish while HKPD’s TA Score has 5 bullish TA indicator(s).
- HITI’s TA Score: 1 bullish, 6 bearish.
- HKPD’s TA Score: 5 bullish, 3 bearish.
Price Growth
HITI (@Drugstore Chains) experienced а -3.96% price change this week, while HKPD (@Medical Distributors) price change was -7.22% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was -2.31%. For the same industry, the average monthly price growth was -5.64%, and the average quarterly price growth was -58.35%.
The average weekly price growth across all stocks in the @Medical Distributors industry was -0.32%. For the same industry, the average monthly price growth was +6.75%, and the average quarterly price growth was -10.02%.
Reported Earning Dates
HITI is expected to report earnings on Sep 16, 2026.
Industries' Descriptions
@Drugstore Chains (-2.31% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
@Medical Distributors (-0.32% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| HITI | HKPD | HITI / HKPD | |
| Capitalization | 192M | 10.4M | 1,846% |
| EBITDA | -2.68M | N/A | - |
| Gain YTD | -17.736 | -47.780 | 37% |
| P/E Ratio | N/A | 6.14 | - |
| Revenue | 671M | N/A | - |
| Total Cash | 27.5M | N/A | - |
| Total Debt | 148M | N/A | - |
HITI | ||
|---|---|---|
OUTLOOK RATING 1..100 | 70 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 33 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 71 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| HITI | HKPD | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 90% |
| Momentum ODDS (%) | 1 day ago 75% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 76% | 1 day ago 88% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 83% |
| Advances ODDS (%) | N/A | 5 days ago 89% |
| Declines ODDS (%) | 5 days ago 81% | 1 day ago 90% |
| BollingerBands ODDS (%) | N/A | 4 days ago 90% |
| Aroon ODDS (%) | 1 day ago 81% | 1 day ago 88% |
Advertisement
HKPD and
Correlation & Price change
A.I.dvisor tells us that HKPD and SCNX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKPD and SCNX's prices will move in lockstep.
| Ticker / NAME | Correlation To HKPD | 1D Price Change % | ||
|---|---|---|---|---|
| HKPD | 100% | -4.33% | ||
| SCNX - HKPD | 31% Poorly correlated | -3.81% | ||
| COSM - HKPD | 16% Poorly correlated | +5.36% | ||
| YI - HKPD | 11% Poorly correlated | +0.50% | ||
| HITI - HKPD | 9% Poorly correlated | -1.36% | ||
| FOCL - HKPD | 7% Poorly correlated | -0.09% | ||
More | ||||